Aurora Pharmaceutical, LLC – Trademark Portfolio
Entity Type: 16
Aurora Pharmaceutical, LLC holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include ALTREN, BARRIER, CLARITY, PRO-TEC, and COCCIAID. The owner is based in Northfield, MN.
1200 S. Highway 3
Northfield, MN 55057
Showing of trademarks Trademarks
Trademark Classifications
Aurora Pharmaceutical, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Aurora Pharmaceutical, LLC have?
Aurora Pharmaceutical, LLC has 20 U.S. trademarks filed with the USPTO. Of these, 11 registered, 8 abandoned, 1 cancelled.
What trademark classes does Aurora Pharmaceutical, LLC file in?
Aurora Pharmaceutical, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Aurora Pharmaceutical, LLC's most well-known trademarks?
Aurora Pharmaceutical, LLC's registered trademark portfolio includes well-known marks such as ALTREN, BARRIER, CLARITY, PRO-TEC, and COCCIAID. These are among 11 currently registered trademarks in the portfolio.
What is Aurora Pharmaceutical, LLC's trademark registration success rate?
Aurora Pharmaceutical, LLC has a 55% trademark registration rate, with 11 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.